UF Health’s newest institute is positioned to amass some of the world’s most talented researchers to tackle Parkinson’s disease and other neurodegenerative disorders and to advance scientific discoveries that lead to breakthroughs in treatment options for patients.
The Norman Fixel Institute for Neurological Diseases is home to scientists and clinicians at UF Health who are working on neurological disorders that afflict millions of people across the globe. These conditions include movement disorders such as Parkinson’s, dystonia and ALS (also known as Lou Gehrig’s disease); dementias such as Alzheimer’s disease and Lewy body disease; and concussions and traumatic brain injuries.
The institute is a cornerstone of the university’s aspiration to help create history’s healthiest generation through precision health, the elimination of health disparities and the advancement of therapies related to the brain and neuromuscular and mental health. UF Health physicians are conducting leading-edge treatments, such as deep brain stimulation and gene therapy, that are transforming patient care.
Under the umbrella of the Fixel Institute, they will seek to revolutionize discoveries in Parkinson’s and other neurological diseases that will lead to new therapies that improve quality of life for patients and forever change how these conditions are treated.